Background: Psoriasis is an inflammatory disease of the skin and joints. Previous studies
have shown a higher prevalence of metabolic syndrome (MS) in psoriatic patients. Recent …

Background Psoriasis is a chronic, immune‐mediated inflammatory skin disease with many
extracutaneous manifestations. Several recent studies have indicated an increased …

Aim: To investigate the prevalence of NAFLD in patients with psoriasis vulgaris. The study
also evaluated the parallel relationship between both of the diseases. Material and methods …

Background Psoriasis has been linked to metabolic syndrome and non‐alcoholic fatty liver
disease (NAFLD). Data suggest that the prevalence of NAFLD is increased in patients with …

Objective: International case-control studies have demonstrated that psoriasis is associated
with an increased prevalence of nonalcoholic fatty liver disease (NAFLD). The purpose of …

BACKGROUND/AIMS: The association between NAFLD and psoriasis has never been
explored in prospective epidemiological studies. The aim of this 2-phase study was to study …

Over the past 10 years, it has become increasingly evident that nonalcoholic fatty liver
disease (NAFLD) is a multisystem disease that affects multiple extra-hepatic organ systems …

Background Psoriasis has been linked to an increased risk of metabolic syndrome (MetS).
Non‐alcoholic fatty liver disease (NAFLD), the hepatic manifestation of MetS, is now the …

Background Recent case-control studies observed an increased prevalence of nonalcoholic
fatty liver disease (NAFLD) in patients with psoriasis, which is relevant in selecting optimal …

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver condition in the West.
The prevalence and severity of NAFLD is higher and the prognosis worse in patients with …